Syntax Research, Inc. Merck & Co., Inc. Transaction History
Syntax Research, Inc.
- $131 Billion
- Q1 2024
A detailed history of Syntax Research, Inc. transactions in Merck & Co., Inc. stock. As of the latest transaction made, Syntax Research, Inc. holds 2,175 shares of MRK stock, worth $275,028. This represents 0.22% of its overall portfolio holdings.
Number of Shares
2,175
Previous 2,175
-0.0%
Holding current value
$275,028
Previous $237 Million
21.03%
% of portfolio
0.22%
Previous 0.2%
Shares
1 transactions
Others Institutions Holding MRK
# of Institutions
3,769Shares Held
1.87BCall Options Held
17.3MPut Options Held
14.8M-
Vanguard Group Inc Valley Forge, PA243MShares$30.8 Billion0.65% of portfolio
-
Black Rock Inc. New York, NY207MShares$26.2 Billion0.65% of portfolio
-
State Street Corp Boston, MA117MShares$14.8 Billion0.7% of portfolio
-
Wellington Management Group LLP Boston, MA86.3MShares$10.9 Billion2.07% of portfolio
-
Geode Capital Management, LLC Boston, MA56.4MShares$7.13 Billion0.7% of portfolio
About Merck & Co., Inc.
- Ticker MRK
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,533,280,000
- Market Cap $320B
- Description
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...